Korean heart drug safety under the microscope
NCT ID NCT07379840
Summary
This study is collecting real-world safety information on finerenone, an approved heart failure medication, as it is used in routine medical practice in South Korea. Researchers will follow 300 adults with chronic heart failure for one year to monitor for any side effects and see how satisfied doctors are with the treatment. No extra tests or visits are required—the study simply observes data from normal patient care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many Locations
RECRUITINGMultiple Locations, South Korea
Conditions
Explore the condition pages connected to this study.